This trial tests new methods and materials for the real-time chemotherapy-associated side effects monitoring support system (RT-CAMSS) in patients with gastrointestinal cancers undergoing chemotherapy. RT-CAMSS is a monitoring support system that provides patients with evidence-based information and side-effect management and coping skills, emotional support and validation, and proactive care via text messages and questionnaires as they undergo chemotherapy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Feasibility and Engagement
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Acceptability
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Symptom distress
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Self-efficacy
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Information and support needs
Timeframe: Prior to start of chemotherapy treatment
Medical information
Timeframe: Baseline
Functional Assessment of Cancer Treatment - General scale
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Social support
Timeframe: Up to 2 months or until chemotherapy is discontinued, whichever is earlier
Post-intervention evaluation
Timeframe: Through study completion, an average of 2 months